Search research articles
Contact Us
Filters
Showing results (161-170 of 224) with videos related to
Page
of 23
Sort By:
Leukemia
|
February 27, 2018
Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV
Susanne Saussele, Rüdiger Hehlmann, Alice Fabarius, et al.
Transplantation and Cellular Therapy
|
December 16, 2022
Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy
Alexander E Perl, Richard A Larson, Nikolai A Podoltsev, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 13, 2019
Favorable radiation field decrease in gastric marginal zone lymphoma : Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL)
Gabriele Reinartz, Regina P Pyra, Georg Lenz, et al.
Cancers
|
August 23, 2020
Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment
Katharina Kriegsmann, Michael Hundemer, Nicole Hofmeister-Mielke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2013
Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trial
Hubert Serve, Utz Krug, Ruth Wagner, et al.
British Journal of Haematology
|
February 29, 2020
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT
Donal P McLornan, Vittoria Malpassuti, Anne Lippinkhof-Kozijn, et al.
Leukemia
|
September 11, 2020
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, et al.
Bone Marrow Transplantation
|
June 25, 2022
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT
Raynier Devillier, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Leukemia
|
May 9, 2020
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, et al.
Hemasphere
|
January 26, 2023
Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT
Alexandros Spyridonidis, Myriam Labopin, Bipin Savani, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 224) with videos related to
Sort By:
Page
of 23
Leukemia
|
February 27, 2018
Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV
Susanne Saussele, Rüdiger Hehlmann, Alice Fabarius, et al.
Transplantation and Cellular Therapy
|
December 16, 2022
Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy
Alexander E Perl, Richard A Larson, Nikolai A Podoltsev, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 13, 2019
Favorable radiation field decrease in gastric marginal zone lymphoma : Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL)
Gabriele Reinartz, Regina P Pyra, Georg Lenz, et al.
Cancers
|
August 23, 2020
Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment
Katharina Kriegsmann, Michael Hundemer, Nicole Hofmeister-Mielke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2013
Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trial
Hubert Serve, Utz Krug, Ruth Wagner, et al.
British Journal of Haematology
|
February 29, 2020
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT
Donal P McLornan, Vittoria Malpassuti, Anne Lippinkhof-Kozijn, et al.
Leukemia
|
September 11, 2020
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, et al.
Bone Marrow Transplantation
|
June 25, 2022
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT
Raynier Devillier, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Leukemia
|
May 9, 2020
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, et al.
Hemasphere
|
January 26, 2023
Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT
Alexandros Spyridonidis, Myriam Labopin, Bipin Savani, et al.
Page
of 23